Sign in

CIK 0001677077 · <br>Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
operating
EIN
811822909
Phone
844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
  1. EFFECT Other Notice of Effectiveness
  2. 8-K Event Shareholder vote results
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-1/A Offering Registration Statement
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. S-1/A Offering Registration Statement
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. DEFA14A Proxy Proxy Materials
  11. S-1 Offering Registration Statement
  12. DEF 14A Proxy Proxy Statement
  13. 8-K Event Regulation FD disclosure
  14. 5 Insider Annual Insider Trading Report
  15. 8-K Event Regulation FD disclosure
  16. 8-K Event Exhibits
  17. PRE 14A Proxy Proxy Statement (Preliminary)
  18. 8-K/A Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  19. 424B5 Offering Prospectus
  20. 8-K Event Material agreement · Regulation FD disclosure

Page 6 of 20 · 398 filings